Filipa Pona-Ferreira

Ms. Filipa Pona-Ferreira

CNS - Campus Neurológico
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
CJConstança Jalles
Constança Jalles
DGDaniela Guerreiro
Daniela Guerreiro
FPFilipa Pona-Ferreira
Filipa Pona-Ferreira
DBDiogo Branco
Diogo Branco
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
Background: Gait impairments are common and highly disabling for Parkinson’s disease (PD) patients. With the development of technology-based tools, it is now possible to measure the spatiotemporal parameters of gait with a reduced margin of error, th


12 May 2020 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
FPFilipa Pona-Ferreira
Filipa Pona-Ferreira
NGNilza Gonçalves
Nilza Gonçalves
MLMariana Leitão
Mariana Leitão
RCRicardo Cacho
Ricardo Cacho
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
Introduction: The satisfactory symptomatic control of the axial symptoms of Parkinson's disease (PD) remains challenging. As these symptoms are an important cause of disability, new therapeutic strategies should be developed and evaluated. To do this, it is necessary to select the outcomes to be measured and reported in a clinical trial. In this study, we sought to identify the most responsive outcome measures for assessing the efficacy of a multidisciplinary intervention on the axial symptoms of PD. Methods: An exploratory prospective clinical study was conducted. PD patients engaged in a pre-defined multidisciplinary intervention program for parkinsonian patients were assessed at admission and discharge by a multidisciplinary team. The responsiveness to intervention was evaluated and the smallest sample size needed to enable statistically significant results for an expected 30% change from baseline for each outcome was calculated. Results: Twenty-two patients were included in the study. The effect size detected varied between 0.04 and 0.83. The Movement Disorder Society—Unified Parkinson's Disease Rating Scale (MDS-UPDRS) total score and each subsection, the N-FOG questionnaire, the 10-m walk test, and Frenchay Dysarthria Assessment-2 Edition (FDA-2) showed a medium to large effect size. Sample size calculations for 90% power and assuming 30% change from baseline ranged from eight to 180 participants. The outcome measures that require a small number of participants to enable statistically significant results were the FDA-2 rating scale (n = 4 participants), the MDS-UPDRS total score (n = 9), the 10-m walk test (n = 9), and the MDS-UPDRS motor examination (n = 10). Conclusions: The MDS-UPDRS part III and total score and the 10-m walk test were the outcomes with the best responsiveness to a multidisciplinary intervention and required a small number of participants to enable statistically significant results. Further studies are needed to clarify the suitability of the Timed Up and Go test.

21 July 2021 in Sensors
Verified
Journal Article
Open access
PDF file
RBRaquel Bouça-Machado
Raquel Bouça-Machado
FPFilipa Pona-Ferreira
Filipa Pona-Ferreira
MLMariana Leitão
Mariana Leitão
ACAna Clemente
Ana Clemente
DVDiogo Vila-Viçosa
Diogo Vila-Viçosa
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
Mobile health (mHealth) has emerged as a potential solution to providing valuable ecological information about the severity and burden of Parkinson’s disease (PD) symptoms in real-life conditions. Objective: The objective of our study was to explore the feasibility and usability of an mHealth system for continuous and objective real-life measures of patients’ health and functional mobility, in unsupervised settings. Methods: Patients with a clinical diagnosis of PD, who were able to walk unassisted, and had an Android smartphone were included. Patients were asked to answer a daily survey, to perform three weekly active tests, and to perform a monthly in-person clinical assessment. Feasibility and usability were explored as primary and secondary outcomes. An exploratory analysis was performed to investigate the correlation between data from the mKinetikos app and clinical assessments. Results: Seventeen participants (85%) completed the study. Sixteen participants (94.1%) showed a medium-to-high level of compliance with the mKinetikos system. A 6-point drop in the total score of the Post-Study System Usability Questionnaire was observed. Conclusions: Our results support the feasibility of the mKinetikos system for continuous and objective real-life measures of a patient’s health and functional mobility. The observed correlations of mKinetikos metrics with clinical data seem to suggest that this mHealth solution is a promising tool to support clinical decisions.

16 March 2025 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
DSDaniela Pimenta da Silva
Daniela Pimenta da Silva
FPFilipa Pona-Ferreira
Filipa Pona-Ferreira
RCRicardo Cacho
Ricardo Cacho
BSBeatriz Santos
Beatriz Santos
TLTeresa Lobo
Teresa Lobo
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira
Parkinson's disease (PD) is a neurodegenerative disorder characterized by both motor and non-motor symptoms, significantly impacting patients’ functionality and quality of life. Clinical exercise, as part of a multidisciplinary approach, is gaining a crucial role in PD management. Goal-based exercises, combining physical activity with cognitive tasks, external feedback and cues, motor sequencing strategies and dual-tasking may enhance motor learning processes and guide physiotherapy programs. Virtual reality (VR) and exergaming have also emerged as promising tools in PD rehabilitation, offering challenging activities in multisensory environments. They provide intensive and repetitive training, augmented feedback, and tailored exercises in highly interactive and enriched environments. Clinical studies have presented promising results in people with PD, supported by neuroimaging studies showing distinct brain activation patterns post-VR training. However, heterogeneity in study design and lack of standardized characterization of VR systems hinder further application in PD rehabilitation. In this review, we appraise the distinguishing features between different VR systems, highlight VR-related motor and cognitive training in PD and explore how VR interventions are aligned with principles of neuroplasticity and motor learning in PD.

4 December 2019 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
MNMaria Ana Neves
Maria Ana Neves
RBRaquel Bouça-Machado
Raquel Bouça-Machado
DGDaniela Guerreiro
Daniela Guerreiro
VCVerónica Caniça
Verónica Caniça
FPFilipa Pona-Ferreira
Filipa Pona-Ferreira
Joaquim FerreiraJoaquim Ferreira
Joaquim Ferreira